BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26242667)

  • 1. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa.
    Schutz C; Ismail Z; Proxenos CJ; Marais S; Burton R; Kenyon C; Maartens G; Wilkinson RJ; Meintjes G
    S Afr Med J; 2012 Mar; 102(6):506-11. PubMed ID: 22668951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes among patients admitted to hospital with antiretroviral and/or antituberculosis drug-induced liver injury.
    Mehta R; Ive P; Evans D; Menezes CN
    S Afr Med J; 2021 Apr; 111(5):474-481. PubMed ID: 34852891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.
    Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
    PLoS One; 2014; 9(4):e94271. PubMed ID: 24714066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.
    Yimer G; Ueda N; Habtewold A; Amogne W; Suda A; Riedel KD; Burhenne J; Aderaye G; Lindquist L; Makonnen E; Aklillu E
    PLoS One; 2011; 6(12):e27810. PubMed ID: 22162992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
    Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
    Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania.
    Mugusi S; Ngaimisi E; Janabi M; Minzi O; Bakari M; Riedel KD; Burhenne J; Lindquist L; Mugusi F; Sandstrom E; Aklillu E
    PLoS One; 2012; 7(7):e40180. PubMed ID: 22808112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
    Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
    Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.
    Marks DJ; Dheda K; Dawson R; Ainslie G; Miller RF
    Int J STD AIDS; 2009 May; 20(5):339-45. PubMed ID: 19386972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.
    Abbara A; Chitty S; Roe JK; Ghani R; Collin SM; Ritchie A; Kon OM; Dzvova J; Davidson H; Edwards TE; Hateley C; Routledge M; Buckley J; Davidson RN; John L
    BMC Infect Dis; 2017 Mar; 17(1):231. PubMed ID: 28340562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.
    Mankhatitham W; Lueangniyomkul A; Manosuthi W
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):651-8. PubMed ID: 21706943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
    Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
    Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
    Chou C; Veracruz N; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Rates of Drug-induced Liver Injury in People Living With HIV Coinfected With Tuberculosis (TB) Irrespective of Antiretroviral Therapy Timing During Antituberculosis Treatment: Results From the Starting Antiretroviral Therapy at Three Points in TB Trial.
    Naidoo K; Hassan-Moosa R; Mlotshwa P; Yende-Zuma N; Govender D; Padayatchi N; Abdool-Karim SSS
    Clin Infect Dis; 2020 Jun; 70(12):2675-2682. PubMed ID: 31622456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.